Harnessing The Power of
NK Cells to Defeat Cancer
"Precision NK therapies have the potential to revolutionize cancer treatment with unsurpassed safety and efficacy. We are excited to bring NK Cell Engager antibodies and CAR-NK cell therapies to initial clinical trials starting in 2021, moving towards broad patient access to cancer-defeating cures."
- Dr. Daniel Teper, Cytovia Therapeutics CEO
Cytovia In The News
Cytovia Therapeutics to Present at Jefferies Virtual London Healthcare Conference
November 12th, 2020
Watch Cytovia's recent webinar at the Jefferies Cell Therapy Virtual Summit, featuring CEO Dr. Daniel Teper and CSO Dr. Wei Lu
October 7th, 2020